Monoclate-P®

Manufacturer: CSL Behring
Generic Name: Antihemophilic Factor VIII (Human) - Monoclonal

Indications: Monoclate-P® is indicated for treatment of classical hemophilia (HemophiliaA). Affected individuals frequently require therapy following minor accidents. Surgery, when required in such individuals, must be preceded by temporary corrections of the clotting abnormality. Surgical prophylaxis in severe AHF deficiency can be accomplished with as appropriately dosed pre-surgical IV bolus of Monoclate-P® followed by intermittent maintenance doses.

Monoclate-P® is not effective in controlling bleeding of patients with von Willebrand's disease.

Monoclate-P® Product Insert

How Supplied: Factor products are supplied in vials sizes of varying International Units (iu). Vial sizes (iu sizes) may change with each new lot of product manufactured. Vial sizes may range from approximately 200 - 1500 iu per vial.

http://www.cslbehring-us.com